期刊
AUTOPHAGY
卷 3, 期 5, 页码 490-492出版社
LANDES BIOSCIENCE
DOI: 10.4161/auto.4592
关键词
chemotherapy; cancer; drug resistance; apoptosis; necroptosis; P-glycoprotein; multidrug resistance-associated protein 1; breast cancer resistant protein
类别
Targeting the weak point of cancers, especially the apoptotic/drug resistant cancers, is critical for the success of cancer chemotherapy. We found that the drug-resistant cancer cell lines overexpressing P-gp, MRP1, BCRP, Bcl-2 and Bcl-xL are susceptible to shikonin, a necroptotic inducer, despite the fact that they are highly resistant to a variety of anticancer agents such as anthracycline antibiotics, vinca alkaloids, taxanes, epipoclophylotoxins, etc. These findings reveal that, although apoptotic/drug resistance is a formidable stronghold of cancer against chemotherapy, necroptotic susceptibility is an intrinsic weak point of cancer. Therefore, targeting the weakness of cancer by induction of necroptosis may have significant potential in cancer chemotherapy, especially in the apoptotic/drug resistant cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据